TITLE

REACHBIO/AXIOGENESIS TO DISTRIBUTE CELL-BASED PRODUCTS

PUB. DATE
April 2008
SOURCE
Worldwide Biotech;Apr2008, Vol. 20 Issue 4, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces that boutique life sciences organization ReachBio LLC will distribute the full product line of biotechnology company Axiogenesis AG to the North American life science research and drug discovery market. It states that the products of Axiogenesis consist of highly pure and well-characterized tissue-specific cells derived from specially engineered mouse embryonic stem cell lines. Rob Chaney, chief operating officer (COO) of ReachBio, talks about the evaluation and characterization of the cell-based products by ReachBio.
ACCESSION #
31446986

 

Related Articles

  • Deals Roundup.  // BioWorld Today;2/28/2008, Vol. 19 Issue 40, p4 

    The article reports that Seattle, Washington-based ReachBio LLC will distribute the full product line of Axiogenesis AG of Cologne, Germany in North America. According to ReachBio, the first cell types available from Axiogenesis are 99.9% pure atrial cardiomyocytes in various formats. It is said...

  • Cor.At Cardiomyocytes.  // Drug Discovery & Development;Aug2008, Vol. 11 Issue 8, p9 

    The article offers brief information on the Cor.At cardiomyocytes embryonic stem cells kit from ReachBio LLC.

  • Burgeoning stem cell product market lures major suppliers. Webb, Sarah // Nature Biotechnology;Jun2010, Vol. 28 Issue 6, p535 

    The article reports on the efforts being done by life sciences suppliers to offer stem cell products in 2010. An agreement was reached by Lonza with Axiogenesis in March to include cardiomyocytes in the former's product catalog. Such cardiomyocytes are derived from mouse embryonic stem cells....

  • Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Sato, Noboru; Meijer, Laurent; Skaltsounis, Leandros; Greengard, Paul; Brivanlou, Ali // Nature Medicine;Jan2004, Vol. 10 Issue 1, p55 

    Human and mouse embryonic stem cells (HESCs and MESCs, respectively) self-renew indefinitely while maintaining the ability to generate all three germ-layer derivatives. Despite the importance of ESCs in developmental biology and their potential impact on tissue replacement therapy, the molecular...

  • News in brief.  // Nature;9/27/2001, Vol. 413 Issue 6854, p340 

    Reports on science-related news and developments. National Science Foundation's awarding of grants to support university-based centres for nanoscale science; Australian parliament committee's recommendation that human embryonic stem-cell research be allowed in all states; Singapore's Economic...

  • Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Stewart, Morag H.; Bossé, Marc; Chadwick, Kristin; Menendez, Pablo; Bendall, Sean C.; Bhatia, Mickie // Nature Methods;Oct2006, Vol. 3 Issue 10, p807 

    Human embryonic stem cell (hESC) lines are known to be morphologically and phenotypically heterogeneous. The functional nature and relationship of cells residing within hESC cultures, however, has not been evaluated because isolation of single hESCs is limited to drug or manual selection. Here...

  • Pitching a different kind of convention - stem cell research. Soule, Alexander // Westchester County Business Journal;3/24/2008, Vol. 47 Issue 12, p32 

    The article reports on the plan of Connecticut legislators to host an international convention for scientists and policymakers on the topic of embryonic stem cell research. Legislators hope to free up funding for the convention and to add $8 million to the state's bioscience facilities fund. On...

  • The gatekeepers of hES cell products. Rabin, Sander // Nature Biotechnology;Jul2005, Vol. 23 Issue 7, p817 

    The article focuses on commercial products derived from human embryonic stem cells (hES). Access to hES cells is presently mediated by a political, legal and economic infrastructure assembled on the foundation of two U.S. patents. Since 2001, federal regulations have divided hES cell research...

  • New Human Embryonic Stem-Cell Lines – More Is Better. Gearhart, John // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1275 

    This article reports on the potential for human embryonic stem cells to provide valuable insight into human biology and possible lead to important medical breakthroughs. Embryonic stem cells are derived from the inner cell mass of blastocysts, the preimplantation stage at which the developing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics